Aptamers Market Size, Share, Growth Analysis, By Type(DNA Aptamers), By Technology(SELEX, Other Technologies, Research & Development, Others), By Application(Therapeutics Development, Research & Development, Diagnostics, Other Applications), By End User(Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Contract Research Organizations, Other End Users), By Region - Industry Forecast 2024-2031

Global Aptamers Market size was valued at USD 155 million in 2022 and is poised to grow from USD 182.59 million in 2023 to USD 677.08 million by 2031, growing at a CAGR of 17.80% during the forecast period (2024-2031).

Rapidly increasing prevalence of chronic diseases around the world and growing use of targeted therapeutics for the treatment of the same are projected to drive up the demand for aptamers over the coming years. Surging demand for early diagnostics and rising investments in the development of novel diagnostic technologies are also expected to benefit aptamers market growth over the coming years. Advancements in SELEX technology are also anticipated to play a crucial role in expanding the business scope of aptamers market players going forward. High investments in medical R&D around the world, rising use of genetic therapies and technologies, and rising awareness regarding the benefits of aptamers are also expected to bolster aptamers market development in the future. On the contrary, short half-life, availability of alternatives, limited acceptance, and stringent regulatory framework are some key constraints that slow down the demand for aptamers. Developed countries such as the United States and Canada are slated to be highly opportune markets for aptamers providers in the long run. 

US Aptamers Market is poised to grow at a sustainable CAGR for the next forecast year.